Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

About the Cover

January 2026; Volume 46,Issue 1

Cover image expansion
Back to top
Previous

In this issue

Anticancer Research: 46 (1)
Anticancer Research
Vol. 46, Issue 1
January 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

Issue highlights

  • Near-infrared Photoimmunotherapy Targeting High-risk Human Neuroblastoma Cells Expressing GD2
  • Efficacy of Magseed Localization for Non-palpable Breast Lesions: A Systematic Review and Meta-analysis
  • Preserved Adrenal Function After Left Renal Cell Carcinoma With Tumor Thrombus Resection and Right Adrenal Vein Ligation: A Case Report
  • THEMIS2 as a Novel Mediator of VEGFR2-driven Angiogenesis in Breast Cancer: Functional Suppression by miR-125b-5p
  • Paucimannosylation Is a Prognostic Marker in High-grade Serous Ovarian Cancer
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Case Reports
  • Corrigenda
  • Top Topics
  • Most Cited
  • Most Read
Loading
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire